Viatris

Milestones as listed on viatris.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.

Leadership as listed on viatris.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.

Products and services as listed on viatris.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.

Sites as listed on viatris.ie, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.

What public registers list for Viatris (group figures): clinical trials it sponsors, FDA device clearances, Irish licences, recent approvals and supply shortages. Rebuilt daily, last on 6 Oct 2026.

Clinical trials 9 in our ClinicalTrials.gov registers · 1 in the EU register

All trials by sponsor name 1 registry name

Drugs in these trials 3 compounds

EU trials register (CTIS) 1 authorised or ongoing

• LUMIOS - A Phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group trial to assess the efficacy, safety and tolerability of cenerimod in adult patients with systemic lupus erythematosus and active lupus nephritis in combination with background therapy2025-522984-14-00 · Phase III · Authorised

Recent approvals

• Ruxolitinib ViatrisEMA · ruxolitinib hemifumarate · 18 Sep 2026 · generic
• Palbociclib ViatrisEMA · palbociclib · 19 Jun 2026 · generic
• Teduglutide ViatrisEMA · teduglutide · 8 Jan 2026 · generic

Medicine shortages 0 in the FDA list · 37 German notices

• Pazopanib Viatris 200 mg FilmtablettenGermany (BfArM) · 1 Apr 2026 to 9 Dec 2026
• Pazopanib Viatris 200 mg FilmtablettenGermany (BfArM) · 1 Apr 2026 to 9 Dec 2026
• Nilotinib Viatris 50 mg HartkapselnGermany (BfArM) · 19 Dec 2025 to 15 Dec 2026
• Arixtra 5 mg/0,4 ml Injektionslösung, Fertigspritze - OP7Germany (BfArM) · 5 Oct 2026 to 17 Nov 2026
• metodura ZNT 50 mg RetardtablettenGermany (BfArM) · 28 Sep 2026 to 20 Nov 2026

A company is listed here when it is named on the shortage record; a shortage can have several manufacturers. See the US and German shortage trackers.

NICE technology appraisals 1 of its medicines · 1 current

• Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosisNICE TA276 · Optimised, Recommended · 27 Mar 2013

Appraisals of medicines sold under a brand this company holds in EMA or FDA records, from our NICE appraisals register. NICE decisions apply to the NHS in England. © NICE 2026 technology appraisal guidance. Available from www.nice.org.uk/guidance. All rights reserved. Subject to Notice of rights. NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

Group (Viatris): founded 2020, headquarters Pittsburgh, website viatris.com/en. Wikidata Q101983981 · Wikipedia. From Wikidata (CC0), matched by the group's SEC filer number.

How this is matched: register records are linked to this page by the organisation name they carry, here Viatris Innovation GmbH; Viatris Inc.; Viatris Pharmaceuticals Co., Ltd.; Viatris Limited; Viatris Healthcare Limited; Mylan S.A.S. and 3 more. Spot a wrong match? Tell us.

From the annual reports Viatris Inc. files with the US Securities and Exchange Commission (10-K, US GAAP), in USD as reported. Latest financial year: to Dec 2025.

R&D is shown as tagged in the filing, which for this company can exclude acquired in-process R&D. Each year is taken from the most recent annual report that includes it, so earlier years reflect any later restatement. Source: SEC EDGAR (XBRL financial data). Compare companies on the pharma company financials register.

Companies registered in Ireland 13 active in the CRO register

From the Companies Registration Office (CRO Open Data, CC BY 4.0). A company is listed when GLEIF's legal entity register links it to Viatris Inc. as its ultimate parent, or when we checked its name and registered address by hand. Branches of foreign companies appear as "External company". Spot a missing or wrong entry? Tell us.